TLR4 and COVID-19: Meidert et al. reported that the differential expression of hsa-miR-3168, hsa-miR-146a-5p, and hsa-let-7e-5p in patients with COVID-19 can affect the expression of inflammation-related genes, including IL-6, IL-8, and Toll-like receptor 4 (TLR4)41.